Influenza A Virus and Mycoplasma pneumoniae Coinfection Mediates Immune Dysregulation and Exacerbates Disease Severity
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110487 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yanan Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Vaccine Research and Development for Major Infectious Diseases in Yunnan Province, Institute of Medical Biology, Chinese Academy of…. Hauptthemen laut MEDLINE: Coinfection, Pneumonia, Mycoplasma, Mycoplasma pneumoniae, Orthomyxoviridae Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project of Medical and Health Science and Technology Innovation, Chinese Academy of Medical Sciences, The Yunnan Provincial Department of Science and Technology, Science and Technology Program.
Abstract (Originalsprache)
Coinfection with influenza virus and Mycoplasma pneumoniae (MP) increases mortality during influenza pandemics; however, its specific impact on Mycoplasma Pneumoniae Pneumonia (MPP) patients or animal models remains unclear. The underlying mechanisms of influenza A virus (IAV)–MP interactions are not fully understood. To investigate the causes of heightened mortality, we established a lethal sequential coinfection mouse model using H3N2 influenza and MP. Coinfection led to prolonged viral persistence, enhanced pulmonary immune cell infiltration, and significantly elevated levels of inflammatory cytokines (IL-6, CCL3, CCL4, and G-CSF; p < 0.05–0.001), culminating in severe pneumonia. Notably, coinfected mice exhibited impaired CD8+ T-cell responses (p < 0.05) and increased pulmonary IL-6 and IL-1α levels (p < 0.05) compared with the controls. Our findings demonstrate that IAV-MP coinfection induces immune-mediated lung injury, which likely contributes to the observed mortality. This study provides critical insights into the immunopathogenesis of coinfection and suggests potential therapeutic targets for managing coinfected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Vaccine Research and Development for Major Infectious Diseases in Yunnan Province, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming 650118, China.
- Department of Industrial Transformation, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.
- Production Department, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China.
- Scientific Research Office, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming 650118, China.
Förderung
- Project of Medical and Health Science and Technology Innovation, Chinese Academy of Medical Sciences
- The Yunnan Provincial Department of Science and Technology, Science and Technology Program
Zitieren
APA
Wu, Y., Zhu, Q., Liu, J., Chuan, H., He, L., Wang, M., Xu, L., Zhang, R., Liu, Y., Liao, G., Li, W., Sun, C., & Zhou, J. (2025). Influenza A Virus and Mycoplasma pneumoniae Coinfection Mediates Immune Dysregulation and Exacerbates Disease Severity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110487
Vancouver
Wu Y, Zhu Q, Liu J, Chuan H, He L, Wang M, et al. Influenza A Virus and Mycoplasma pneumoniae Coinfection Mediates Immune Dysregulation and Exacerbates Disease Severity. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110487
BibTeX
@article{Wu2025,
author = {Wu, Yanan and Zhu, Qi and Liu, Jing and Chuan, Hongyun and He, Lingyu and Wang, Mingqing and Xu, Lilan and Zhang, Runfang and Liu, Yao and Liao, Guoyang and Li, Weidong and Sun, Chengquan and Zhou, Jian},
title = {Influenza A Virus and Mycoplasma pneumoniae Coinfection Mediates Immune Dysregulation and Exacerbates Disease Severity},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110487}
}
EUVIMED